Nurse Practitioner · Lake Charles, LA
NPI
1083056915
Since 2013
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2770 3rd Ave Ste 210
Lake Charles, LA, 70601
Phone (337) 494-6768
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
269 services
Medicare patients, 2024
107
Average age 69
Drug cost, 2024
$3.9M
1,751 prescriptions
Company payments, 2025
$3,168
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lacey W Vasilakis was code 99214 (office e&m - established), 184 times for 72 patients. In total Lacey W Vasilakis billed 269 services in 6 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 184 | 72 | $58.04 | $11K |
| 99213 Office E&M - Established | Facility | 65 | 55 | $30.08 | $1,955 |
| 99215 Office E&M - Established | Facility | 16 | 11 | $91.63 | $1,466 |
By year: 2022 $31K for 619 services; 2023 $23K for 438 services; 2024 $14K for 269 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lacey W Vasilakis prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 184 prescriptions and refills. In total Lacey W Vasilakis wrote 1,751 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 184 | 185 | 42 | $5,581 |
| Anastrozole Generic | 106 | 259 | 43 | $1,681 |
| Ondansetron Hcl Generic | 71 | 71 | 39 | $875 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 65 | 65 | 21 | $1,088 |
| Letrozole Generic | 55 | 113 | 12 | $1,044 |
| Gabapentin Generic | 50 | 59 | 13 | $487 |
| Oxycodone Hcl Generic | 48 | 48 | Under 11 | $1,837 |
| Ibrance Palbociclib | 41 | 41 | Under 11 | $670K |
| Temazepam Generic | 36 | 36 | Under 11 | $125 |
| Alprazolam Generic | 34 | 35 | Under 11 | $127 |
| Tamsulosin Hcl Generic | 33 | 63 | Under 11 | $151 |
| Morphine Sulfate Generic | 31 | 31 | Under 11 | $2,015 |
| Dexamethasone Generic | 30 | 41 | 11 | $799 |
| Imbruvica Ibrutinib | 30 | 30 | Under 11 | $543K |
| Montelukast Sodium Generic | 28 | 44 | Under 11 | $165 |
Brand drugs: 272 claims; generic drugs: 1,479 claims; opioid claims: 371.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lacey W Vasilakis $3,168 ($3,168 in general payments such as food, travel and fees) from 46 companies. The largest payer was Daiichi Sankyo Inc. with $274.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 8 | $274 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $253 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $239 |
| Merck Sharp & Dohme LLC MRK | 7 | $196 |
| Astellas Pharma US Inc 4503.T | 6 | $187 |
| Pfizer Inc. PFE | 8 | $165 |
| Celgene Corporation BMY | 7 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $111 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $109 |
| Abbvie Inc. ABBV | 5 | $106 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.